Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flibanserin PET study in premenopausal women with generalized acquired hypoactive sexual desire disorder
NL-OMON34777Withdrawn
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of flibanserin in hypoactive sexual desire disorder (HSDD), sponsored by Boehringer Ingelheim. Planned start Feb 2010; status: withdrawn.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NL-OMON34777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34777.